Total Funding
75
1
Total FundingDebt Financing raised
Growth Score
-7 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
648453
Single Cell Technology has developed a technology for analyzing antibodies and mRNA from cells called AbTheneum.
Chun-Nan Chen: Founder, CEO and CSO- Erik Babajanian: Chief Financial Officer
About the Company
Single Cell Technology Inc., a biotechnology company, develops and licenses a technology platform that discovers and analyzes antibodies and mRNA from individual antibody secreting cells. The company’s platform examines and screens plasma cells in lymphoid tissues against various molecules in various hosts, including humans, mouse cells, and other
organisms for measuring their affinity and specificity from cognate light and heavy chains. It also offers contract services for the antibody repertoire of immune response to pharmaceutical and biopharmaceutical companies. The company was incorporated in 2008 and is based in San Jose, California.
